Mun Kein-Seong, Cheah Phaik-Leng, Baharudin Nurul Bahiyah, Looi Lai-Meng
Department of Pathology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Malays J Pathol. 2006 Dec;28(2):73-7.
Hepatocellular carcinoma (HCC) is among the ten most common cancers in Malaysian males. As cellular proliferation is an important feature of malignant transformation, we studied the proliferation pattern of normal and benign perineoplastic liver versus hepatocellular carcinoma in an attempt to further understand the tumour transformation process. 39 HCC (21 with accompanying and 18 without cirrhosis) histologically diagnosed at the Department of Pathology, University of Malaya Medical Centre between January 1992 and December 2003 were immunohistochemically studied using a monoclonal antibody to PCNA (Clone PC10: Dako). 20 livers from cases who had succumbed to traumatic injuries served as normal liver controls (NL). PCNA labeling index (PCNA-LI) was determined by counting the number of immunopositive cells in 1000 contiguous HCC, benign cirrhotic perineoplastic liver (BLC), benign perineoplastic non-cirrhotic (BLNC) and NL cells and conversion to a percentage. The PCNA-LI was also expressed as Ojanguren et al's grades. PCNA was expressed in 10% NL, 38.9% BLNC, 76.2% BLC and 71.8% HCC with BLNC, BLC and HCC showing significantly increased (p < 0.05) number of cases which expressed PCNA compared with NL. The number of BLC which expressed PCNA was also significantly increased compared with BLNC. PCNA-LI ranged from 0-2.0% (mean = 0.2%) in NL, 0-2.0% (mean = 0.3%) in BLNC, 0-3.6% (mean = 0.7%) in BLC and 0-53.8% (mean = 7.6%) in HCC with PCNA-LI significantly increased (p < 0.05) only in HCC compared with BLC, BLNC and NL. Accordingly, all NL, BLC and BLNC showed minimal (<5% cells being immunopositive) immunoreactivity on Ojanguren et al's grading system and only HCC demonstrated immunoreactivity which ranged up to grade 3 (75% of cells). From this study, there appears to be a generally increasing trend of proliferative activity from NL to BLNC to BLC and HCC. Nonetheless, BLNC and BLC, like NL, retained low PCNA-LI and only HCC had a significantly increased PCNA-LI compared with the benign categories. This is probably related to the malignant nature of HCC and may reflect the uncontrolled proliferation of the neoplastic hepatocytes.
肝细胞癌(HCC)是马来西亚男性中最常见的十种癌症之一。由于细胞增殖是恶性转化的一个重要特征,我们研究了正常和良性肿瘤周围肝组织与肝细胞癌的增殖模式,试图进一步了解肿瘤转化过程。1992年1月至2003年12月期间,在马来亚大学医学中心病理科经组织学诊断的39例HCC(21例伴有肝硬化,18例无肝硬化),使用抗PCNA单克隆抗体(克隆PC10:Dako)进行免疫组织化学研究。20例因创伤性损伤死亡病例的肝脏作为正常肝脏对照(NL)。PCNA标记指数(PCNA-LI)通过计算1000个连续的HCC、良性肝硬化肿瘤周围肝组织(BLC)、良性非肝硬化肿瘤周围肝组织(BLNC)和NL细胞中的免疫阳性细胞数量并换算为百分比来确定。PCNA-LI也按照奥扬古伦等人的分级表示。PCNA在10%的NL、38.9%的BLNC、76.2%的BLC和71.8%的HCC中表达,与NL相比,BLNC、BLC和HCC中表达PCNA的病例数显著增加(p<0.05)。与BLNC相比,表达PCNA的BLC数量也显著增加。PCNA-LI在NL中范围为0 - 2.0%(平均 = 0.2%),在BLNC中为0 - 2.0%(平均 = 0.3%),在BLC中为0 - 3.6%(平均 = 0.7%),在HCC中为0 - 53.8%(平均 = 7.6%),仅HCC的PCNA-LI与BLC、BLNC和NL相比显著增加(p<0.05)。因此,根据奥扬古伦等人的分级系统,所有NL、BLC和BLNC的免疫反应性均最低(<5%的细胞为免疫阳性),只有HCC表现出高达3级(75%的细胞)的免疫反应性。从这项研究来看,从NL到BLNC到BLC再到HCC,增殖活性似乎总体呈上升趋势。尽管如此,BLNC和BLC与NL一样,PCNA-LI保持较低水平,只有HCC与良性类别相比PCNA-LI显著增加。这可能与HCC的恶性性质有关,可能反映了肿瘤性肝细胞的不受控制的增殖。